New Chromosomal Microarray with Two-day Turnaround

Thermo Fisher Scientific has introduced a ground-breaking chromosomal microarray, the Applied Biosystems™ CytoScan™ HD Accel array, boasting an industry-leading two-day turnaround time. Designed to enhance productivity, efficiency, and profitability in cytogenetic research labs, it provides insights into chromosomal variants for a broad range of applications, including prenatal, postnatal, and oncology research.

In the face of growing demand and a shortage of trained lab professionals, labs are increasingly pressured to improve efficiency. The CytoScan HD Accel array can elevate assay productivity by up to 100% using existing equipment, reducing sample handling and preparation time. Remarkably, it requires as little as 100 ng of input DNA, significantly less than other commercially available chromosomal microarrays.

Kevin Lowitz, Vice President and General Manager of Microarray Genetic Solutions at Thermo Fisher Scientific, highlighted the array's capacity to save labs weeks or even months annually. With its scalability and ability to deliver reliable, reproducible results swiftly, microarray technology emerges as a cost-effective choice for cytogenetic research.

The CytoScan HD Accel array offers improved data quality through an expanded reference model, accommodating various sample types, from buccal swabs to blood. Thermo Fisher continues to support customers in advancing cytogenetic research, with updates to its instrumentation and services, including enhanced data analysis software and instrument upgrades for array processing.

More information online